Evidence map›Paper›PMID 32776212›Full record

ReviewTopics in current chemistry (Cham)2020

Recent Advances in the Synthesis of Perimidines and their Applications.

Nusrat Sahiba, Shikha Agarwal

Open access · bronzeAbstract readReview
In one paragraph

Review in Topics in current chemistry (Cham), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. CuFeScientific reports · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Syntheses and crystal structures of 2-(Acta crystallographica. Section E, Crystallographic communications · 2022
    Article
  8. Synthesis and comparative structural study of 2-(pyridin-2-yl)-1Acta crystallographica. Section E, Crystallographic communications · 2021
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nusrat SahibaSynthetic Organic Chemistry Laboratory, Department of Chemistry, MLSU, Udaipur, 313001, India.
Shikha AgarwalSynthetic Organic Chemistry Laboratory, Department of Chemistry, MLSU, Udaipur, 313001, India. shikhaagarwal@mlsu.ac.in.ORCID http://orcid.org/0000-0003-2946-0409
Laboratoire de Synthèse Organique · FR

Funding

Council of Scientific and Industrial Research, India 09/172(0088)2018-EMR-I
6 · The paper itself

Abstract

Perimidines are versatile scaffolds and a fascinating class of N-heterocycles that have evolved significantly in recent years due to their immense applications in life sciences, medical sciences, and industrial chemistry. Their ability of molecular interaction with different proteins, complex formation with metals, and distinct behavior in various ranges of light makes them more appealing and challenging for future scientists. Various novel technologies have been developed for the selective synthesis of perimidines and their conjugated derivatives. These methods extend to the preparation of different bioactive and industrially applicable molecules. This review aims to present the most recent advancements in perimidine synthesis under varied conditions like MW radiation, ultrasound, and grinding using different catalysts such as ionic liquids, acid, metal, and nanocatalyst and also under green environments like catalyst and solvent-free synthesis. The applications of perimidine derivatives in drug discovery, polymer chemistry, photo sensors, dye industries, and catalytic activity in organic synthesis are discussed in this survey. This article is expected to be a systematic, authoritative, and critical review on the chemistry of perimidines that compiles most of the state-of-art innovation in this area.

Indexed as

Drug DiscoveryMolecular StructureQuinazolinesUltrasonic WavesperimidineQuinazolinesBiologic activityCatalysisN-heterocyclesPerimidinesSynthesis

Identifiers

PMID32776212
PMCPMC7415412
OpenAlexW3047797028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.